This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery. Extensive contributions examine recent controversial court decisions in patent law – such as Bilski v. Kappos, and the litigation over Myriad’s patents in respect of BRCA1 and BRCA2 – while other papers explore sui generis fields, such as access to genetic resources, plant breeders’ rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges – such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects – such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies. Intellectual Property and Emerging Technologies will appeal to policy-makers, legal practitioners, business managers, inventors, scientists, and researchers.
Note
This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery. Extensive contributions examine recent controversial court decisions in patent law – such as Bilski v. Kappos, and the litigation over Myriad’s patents in respect of BRCA1 and BRCA2 – while other papers explore sui generis fields, such as access to genetic resources, plant breeders’ rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges – such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects – such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies. Intellectual Property and Emerging Technologies will appeal to policy-makers, legal practitioners, business managers, inventors, scientists, and researchers.
Bibliography, etc. Note
Includes bibliographical references (pages 392-455) and index.
Formatted Contents Note
Preface Introduction: Inventing Life: Intellectual Property and the New Biology Part I: A History of Biodiscovery - 1. Of Plants, Pills and Patents: Circulating Knowledge Part II: Medicine, Biotechnology And Genomics - 2. Bilski v. Kappos and Biotechnology Patents: Back to the Future?; 3. The Current State of Patent Eligibility of Medical and Biotechnology Inventions in the United States; 4. Patent Law, the Emerging Biotechnologies and the Role of Language in Subject-Matter Expansionism Part III: Biobanks, Bioinformatics and Biobricks - 5. Standards for Biobank Access and Intellectual Property; 6. The 1000 Genomes Project; 7. Building with BioBricks: Constructing a Commons for Synthetic Biology Research Part IV: Genetics, Stem Cells and Nanotechnology - 8. Regulating Gene Regulation: Patenting Small RNAs; 9. Stem Cell Patents: Looking for Serenity; 10. Cosmo, Cosmolino: Patent Law and Nanotechnology Part V: Biodiversity, Food Security and Climate Change - 11. Patenting the Kakadu Plum and the Marjarla Tree: Biodiscovery, Intellectual Property and Indigenous Knowledge; 12. Climate-Ready Crops: Intellectual Property, Agriculture and Climate Change; 13. The Doomsday Vault: Seed Banks, Food Security and Climate Change – Bibliography Index